Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0005929 | cilium | 4 | 2 |
GO:0031514 | motile cilium | 5 | 2 |
GO:0042995 | cell projection | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
Related structures:
AlphaFold database: Q4QH99
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.210 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.212 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.159 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 240 | 242 | PF00675 | 0.219 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.211 |
CLV_NRD_NRD_1 | 274 | 276 | PF00675 | 0.255 |
CLV_NRD_NRD_1 | 299 | 301 | PF00675 | 0.284 |
CLV_NRD_NRD_1 | 329 | 331 | PF00675 | 0.219 |
CLV_NRD_NRD_1 | 340 | 342 | PF00675 | 0.176 |
CLV_NRD_NRD_1 | 405 | 407 | PF00675 | 0.228 |
CLV_NRD_NRD_1 | 427 | 429 | PF00675 | 0.201 |
CLV_NRD_NRD_1 | 440 | 442 | PF00675 | 0.202 |
CLV_NRD_NRD_1 | 456 | 458 | PF00675 | 0.141 |
CLV_NRD_NRD_1 | 472 | 474 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.515 |
CLV_PCSK_FUR_1 | 209 | 213 | PF00082 | 0.304 |
CLV_PCSK_FUR_1 | 297 | 301 | PF00082 | 0.291 |
CLV_PCSK_FUR_1 | 327 | 331 | PF00082 | 0.211 |
CLV_PCSK_FUR_1 | 403 | 407 | PF00082 | 0.304 |
CLV_PCSK_FUR_1 | 425 | 429 | PF00082 | 0.213 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.225 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.545 |
CLV_PCSK_KEX2_1 | 153 | 155 | PF00082 | 0.224 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.262 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.227 |
CLV_PCSK_KEX2_1 | 240 | 242 | PF00082 | 0.210 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.197 |
CLV_PCSK_KEX2_1 | 299 | 301 | PF00082 | 0.284 |
CLV_PCSK_KEX2_1 | 329 | 331 | PF00082 | 0.206 |
CLV_PCSK_KEX2_1 | 340 | 342 | PF00082 | 0.190 |
CLV_PCSK_KEX2_1 | 405 | 407 | PF00082 | 0.304 |
CLV_PCSK_KEX2_1 | 425 | 427 | PF00082 | 0.114 |
CLV_PCSK_KEX2_1 | 472 | 474 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.519 |
CLV_PCSK_PC1ET2_1 | 153 | 155 | PF00082 | 0.229 |
CLV_PCSK_PC7_1 | 144 | 150 | PF00082 | 0.153 |
CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.482 |
CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.211 |
CLV_PCSK_SKI1_1 | 472 | 476 | PF00082 | 0.445 |
DEG_APCC_DBOX_1 | 471 | 479 | PF00400 | 0.464 |
DOC_MAPK_gen_1 | 192 | 200 | PF00069 | 0.396 |
DOC_MAPK_gen_1 | 263 | 271 | PF00069 | 0.425 |
DOC_MAPK_gen_1 | 297 | 306 | PF00069 | 0.504 |
DOC_MAPK_gen_1 | 472 | 478 | PF00069 | 0.575 |
DOC_MAPK_MEF2A_6 | 193 | 202 | PF00069 | 0.400 |
DOC_PP2B_LxvP_1 | 465 | 468 | PF13499 | 0.411 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.474 |
DOC_USP7_UBL2_3 | 372 | 376 | PF12436 | 0.447 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.508 |
LIG_14-3-3_CanoR_1 | 133 | 141 | PF00244 | 0.529 |
LIG_14-3-3_CanoR_1 | 16 | 24 | PF00244 | 0.533 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.545 |
LIG_CaM_IQ_9 | 197 | 213 | PF13499 | 0.482 |
LIG_CaM_IQ_9 | 227 | 243 | PF13499 | 0.447 |
LIG_CaM_IQ_9 | 386 | 402 | PF13499 | 0.504 |
LIG_FHA_1 | 402 | 408 | PF00498 | 0.447 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.496 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.421 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.669 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.539 |
LIG_PCNA_yPIPBox_3 | 376 | 387 | PF02747 | 0.498 |
LIG_REV1ctd_RIR_1 | 1 | 11 | PF16727 | 0.627 |
LIG_SH2_STAT3 | 161 | 164 | PF00017 | 0.467 |
LIG_SH2_STAT3 | 280 | 283 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 280 | 283 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 335 | 338 | PF00017 | 0.504 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.525 |
LIG_SUMO_SIM_anti_2 | 412 | 417 | PF11976 | 0.411 |
LIG_SUMO_SIM_anti_2 | 43 | 49 | PF11976 | 0.414 |
LIG_TRAF2_1 | 100 | 103 | PF00917 | 0.581 |
LIG_TRAF2_1 | 76 | 79 | PF00917 | 0.590 |
LIG_WW_3 | 12 | 16 | PF00397 | 0.455 |
MOD_CDK_SPK_2 | 94 | 99 | PF00069 | 0.410 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.691 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.429 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.624 |
MOD_CK2_1 | 97 | 103 | PF00069 | 0.598 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.215 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.597 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.489 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.586 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.477 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.582 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.497 |
MOD_PKA_2 | 348 | 354 | PF00069 | 0.484 |
MOD_PKB_1 | 15 | 23 | PF00069 | 0.498 |
MOD_Plk_1 | 409 | 415 | PF00069 | 0.401 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.503 |
MOD_SUMO_rev_2 | 122 | 131 | PF00179 | 0.425 |
MOD_SUMO_rev_2 | 228 | 236 | PF00179 | 0.447 |
MOD_SUMO_rev_2 | 268 | 278 | PF00179 | 0.425 |
MOD_SUMO_rev_2 | 452 | 459 | PF00179 | 0.511 |
TRG_DiLeu_BaEn_1 | 115 | 120 | PF01217 | 0.395 |
TRG_DiLeu_BaEn_3 | 381 | 387 | PF01217 | 0.411 |
TRG_DiLeu_BaEn_4 | 435 | 441 | PF01217 | 0.491 |
TRG_ER_diArg_1 | 14 | 17 | PF00400 | 0.547 |
TRG_ER_diArg_1 | 185 | 188 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 209 | 212 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 239 | 241 | PF00400 | 0.420 |
TRG_ER_diArg_1 | 246 | 248 | PF00400 | 0.400 |
TRG_ER_diArg_1 | 297 | 300 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 326 | 329 | PF00400 | 0.429 |
TRG_ER_diArg_1 | 403 | 406 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 425 | 428 | PF00400 | 0.401 |
TRG_ER_diArg_1 | 471 | 473 | PF00400 | 0.467 |
TRG_ER_diArg_1 | 81 | 83 | PF00400 | 0.564 |
TRG_NES_CRM1_1 | 221 | 234 | PF08389 | 0.546 |
TRG_Pf-PMV_PEXEL_1 | 133 | 137 | PF00026 | 0.300 |
TRG_Pf-PMV_PEXEL_1 | 246 | 250 | PF00026 | 0.211 |
TRG_Pf-PMV_PEXEL_1 | 385 | 390 | PF00026 | 0.282 |
TRG_Pf-PMV_PEXEL_1 | 405 | 409 | PF00026 | 0.114 |
TRG_Pf-PMV_PEXEL_1 | 457 | 461 | PF00026 | 0.200 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5W7 | Leptomonas seymouri | 78% | 100% |
A0A0S4INS9 | Bodo saltans | 47% | 98% |
A0A1X0NS36 | Trypanosomatidae | 57% | 100% |
A0A3S7WRD8 | Leishmania donovani | 97% | 100% |
A0A422NGP1 | Trypanosoma rangeli | 55% | 100% |
A0A480NP79 | Sus scrofa | 31% | 87% |
A4H6A3 | Leishmania braziliensis | 91% | 100% |
A4HUM7 | Leishmania infantum | 97% | 100% |
A8I9E8 | Chlamydomonas reinhardtii | 44% | 96% |
C9ZVQ8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9ANC5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q32LN4 | Bos taurus | 32% | 87% |
Q9D9U9 | Mus musculus | 32% | 87% |
Q9UL16 | Homo sapiens | 31% | 87% |
V5BJP2 | Trypanosoma cruzi | 58% | 99% |